Unexplained weight loss (UWL), defined as a loss of more than 5% of the total body weight within a span of six months, is a common yet perplexing clinical scenario. It is often a harbinger of serious underlying pathology, necessitating a thorough evaluation. This article aims to provide a comprehensive approach to the evaluation of UWL in clinical practice.
The initial evaluation should focus on a detailed history and physical examination. It is important to ascertain the time frame, amount of weight loss, and associated symptoms. A meticulous review of systems can often hint at the underlying cause. The role of medications, diet, and lifestyle changes should be explored. Physical examination should be comprehensive, focusing on signs of systemic diseases.
Basic laboratory studies should be done, including complete blood count, metabolic panel, liver function tests, thyroid function tests, and tumor markers. Imaging studies, such as CT scans or ultrasound, should be considered based on the clinical suspicion. Endoscopic procedures might be necessary in cases with gastrointestinal symptoms.
If the initial workup is unrevealing, specialized evaluations might be warranted. These could include psychiatric evaluation for eating disorders or depression, rheumatologic workup for connective tissue diseases, or oncologic evaluation for suspected malignancies. The choice of further investigations should be guided by the clinical picture.
Patients with UWL should be closely monitored. If no cause is found despite a thorough evaluation, careful follow-up is essential as some conditions might manifest later. Any new symptoms or signs should prompt a re-evaluation.
Evaluating UWL is a complex task requiring a systematic approach. A meticulous history, physical examination, and judicious use of investigations can often lead to the diagnosis. Close follow-up is crucial in cases where the cause remains elusive. By adopting a comprehensive approach, clinicians can ensure optimal care for patients experiencing UWL.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation